Radiotherapy is effective in patients with glioblastoma multiforme with a limited prognosis and in patients above 70 years of age: A retrospective single institution analysis

Radiotherapy and Oncology

Volumn 75, Issue 2, 2005, Pages 210-216

  Marijnen, Corrie A M ^a   Van Den Berg, Sylvia M P ^a   Van Duinen, Sjoerd G ^a   Voormolen, Joan H C ^a   Noordijk, Ed M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Elderly; Glioblastoma multiforme; Radiotherapy; Recursive partitioning analysis; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME;

AGE FACTORS; AGED; BRAIN NEOPLASMS; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 20444389006     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2005.03.004     Document Type: Article

References (20)

1. N. Laperriere, L. Zuraw, and G. Cairncross Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review Radiother Oncol 64 2002 259 273
2. J.L. Chan, S.W. Lee, and B.A. Fraass Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy J Clin Oncol 20 2002 1635 1642
3. B.G. Baumert, J. Lutterbach, R. Bernays, J.B. Davis, and F.L. Heppner Fractionated stereotactic radiotherapy boost after post-operative radiotherapy in patients with high-grade gliomas Radiother Oncol 67 2003 183 190
4. C.H. Chang, J. Horton, and D. Schoenfeld Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study Cancer 52 1983 997 1007
5. R. Stupp, W.P. Mason, M.J. van den Bent, M. Weller, M.J. Fisher, and M.J. Taphoorn Concomitant and adjuvant temozolomide and radiotherapy for newly diagnosed glioblastoma multiforme. Conclusive results of a randomized phase III trial by the EORTC Brain and RT groups and the NCIC clinical trials group Proc Am Soc Clin Oncol 23 2004 [abs #2]
6. E.L. Chang, W. Yi, P.K. Allen, V.A. Levin, R.E. Sawaya, and M.H. Maor Hypofractionated radiotherapy for elderly or younger low-performance status glioblastoma patients: outcome and prognostic factors Int J Radiat Oncol Biol Phys 56 2003 519 528
7. M.C. Hulshof, E.C. Schimmel, B.D. Andries, and G.D. Gonzalez Hypofractionation in glioblastoma multiforme Radiother Oncol 54 2000 143 148
8. L. Kleinberg, T. Slick, C. Enger, S. Grossman, H. Brem, and M.D. Wharam Jr Short course radiotherapy is an appropriate option for most malignant glioma patients Int J Radiat Oncol Biol Phys 38 1997 31 36
9. J.J. McAleese, S.P. Stenning, and S. Ashley Hypofractionated radiotherapy for poor prognosis malignant glioma: matched pair survival analysis with MRC controls Radiother Oncol 67 2003 177 182
10. C. Phillips, M. Guiney, J. Smith, P. Hughes, K. Narayan, and G. Quong A randomized trial comparing 35 Gy in ten fractions with 60 Gy in 30 fractions of cerebral irradiation for glioblastoma multiforme and older patients with anaplastic astrocytoma Radiother Oncol 68 2003 23 26
11. B.J. Slotman, J.H. Kralendonk, H.A. van Alphen, W. Kamphorst, and A.B. Karim Hypofractionated radiation therapy in patients with glioblastoma multiforme: results of treatment and impact of prognostic factors Int J Radiat Oncol Biol Phys 34 1996 895 898
12. W.J. Curran Jr, C.B. Scott, and J. Horton Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials J Natl Cancer Inst 85 1993 704 710
13. S. Gundersen, K. Lote, and E. Hannisdal Prognostic factors for glioblastoma multiforme-development of a prognostic index Acta Oncol 35 1996 123 127
14. M.C. Hulshof, R.W. Koot, E.C. Schimmel, F. Dekker, D.A. Bosch, and G.D. Gonzalez Prognostic factors in glioblastoma multiforme. 10 years experience of a single institution Strahlenther Onkol 177 2001 283 290
15. J.N. Scott, N.B. Rewcastle, and P.M. Brasher Which glioblastoma multiforme patient will become a long-term survivor? A population-based study Ann Neurol 46 1999 183 188
16. C.B. Scott, C. Scarantino, and R. Urtasun Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06 Int J Radiat Oncol Biol Phys 40 1998 51 55
17. D.S. Mohan, J.H. Suh, J.L. Phan, P.A. Kupelian, B.H. Cohen, and G.H. Barnett Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution Int J Radiat Oncol Biol Phys 42 1998 981 987
18. S. Villa, N. Vinolas, and E. Verger Efficacy of radiotherapy for malignant gliomas in elderly patients Int J Radiat Oncol Biol Phys 42 1998 977 980
19. W. Roa, P.M. Brasher, and G. Bauman Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial J Clin Oncol 22 2004 1583 1588
20. Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: a Medical Research Council trial J Clin Oncol 19 2001 509 518